Cap displayed in your preferred currency (USD)
Industries & Sectors
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| North America (Primary) | PRIMARYNOAM | Univ | 8,182 | 57,735,260 | 1.17% | 0.69% | -0.55% | 3.20% | 17.21% | 22.70% |
| Healthcare | HEALTHCARE | Sector | 1,343 | 6,388,469 | 0.29% | 1.41% | -0.56% | -1.12% | 15.27% | 9.49% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 680 | 2,955,318 | 0.10% | 2.57% | -1.73% | -2.72% | 23.89% | 24.55% |
| Other Biopharmaceuticals | BIOPHARMAOTHER | Industry | 114 | 1,111,268 | 1.42% | 3.65% | 2.01% | 2.12% | 20.88% | 31.52% |
| Diversified Biopharmaceuticals | BIOPHARMADIV | SubInd | 83 | 1,102,608 | 1.42% | 3.59% | 2.00% | 2.10% | 20.73% | 31.51% |
Show Stocks
Sort: 1Mo %
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Alvotech | ALVO:USAALVO:USA | Stock | 1 | 3,842 | -0.76% | 1.77% | 23.39% | -7.04% | 61.80% | 49.38% |
| Sana Biotechnology, Inc. | SANA:USASANA:USA | Stock | 1 | 2,066 | 6.75% | 19.72% | 22.68% | 73.13% | 238.96% | 81.57% |
| Blueprint Medicines Corp. | BPMC:USABPMC:USA | Stock | 1 | 6,709 | 0.18% | 15.26% | 18.21% | 39.83% | 80.45% | 83.51% |
| Amgen, Inc. | AMGN:USAAMGN:USA | Stock | 1 | 166,976 | 11.82% | 15.30% | 16.11% | -2.56% | 18.61% | 38.76% |
| Amneal Pharmaceuticals, Inc. | AMRX:USAAMRX:USA | Stock | 1 | 2,072 | 8.86% | 15.16% | 13.42% | 22.46% | 62.89% | 267.39% |
| IGM Biosciences, Inc. | IGMS:USAIGMS:USA | Stock | 1 | 591 | 6.79% | 7.13% | 13.27% | -15.73% | 112.90% | -19.95% |
| Avidity Biosciences, Inc. | RNA:USARNA:USA | Stock | 1 | 2,097 | 3.40% | 8.58% | 11.65% | 127.23% | 422.73% | 136.16% |
| Organon & Co. | OGN:USAOGN:USA | Stock | 1 | 5,017 | 0.56% | 5.71% | 9.74% | 24.13% | 55.69% | -4.86% |
| ADMA Biologics, Inc. | ADMA:USAADMA:USA | Stock | 1 | 1,539 | 1.04% | 3.97% | 8.44% | 31.47% | 97.39% | 99.12% |
| Pfizer Inc. | PFE:USAPFE:USA | Stock | 1 | 157,015 | 0.40% | 9.49% | 4.35% | 4.67% | -6.20% | -23.51% |
| Perrigo Co. Plc | PRGO:USAPRGO:USA | Stock | 1 | 4,443 | -0.82% | 2.66% | 4.26% | 3.39% | 20.03% | -8.06% |
| Kymera Therapeutics, Inc. | KYMR:USAKYMR:USA | Stock | 1 | 2,295 | 3.03% | 12.08% | 3.20% | 10.39% | 209.60% | 42.53% |
| Amphastar Pharmaceuticals, Inc. | AMPH:USAAMPH:USA | Stock | 1 | 2,041 | -0.47% | 3.28% | 2.26% | -18.89% | -6.58% | 16.14% |
| Diversified Biopharmaceuticals | BIOPHARMADIV | SubInd | 83 | 1,102,608 | 1.42% | 3.59% | 2.00% | 2.10% | 20.73% | 31.51% |
| MannKind Corp. | MNKD:USAMNKD:USA | Stock | 1 | 1,185 | 0.23% | 3.78% | 1.86% | 35.08% | 10.30% | 12.85% |
| Prestige Consumer Healthcare, Inc. | PBH:USAPBH:USA | Stock | 1 | 3,475 | -1.77% | -0.67% | 0.32% | 13.20% | 18.30% | 12.87% |
| Viatris, Inc. | VTRS:USAVTRS:USA | Stock | 1 | 14,145 | 1.55% | 1.82% | 0.17% | 2.73% | 34.94% | 36.78% |
| Merck & Co., Inc. | MRK:USAMRK:USA | Stock | 1 | 322,945 | -0.58% | -2.81% | -0.12% | 1.70% | 25.67% | 11.61% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,779 | 75,176,635 | 1.24% | 0.60% | -0.35% | 4.13% | 19.55% | 28.03% |
| ANI Pharmaceuticals, Inc. | ANIP:USAANIP:USA | Stock | 1 | 1,377 | 0.21% | 2.89% | -1.02% | 20.00% | 7.50% | 76.79% |
| Royalty Pharma plc | RPRX:USARPRX:USA | Stock | 1 | 12,691 | -1.22% | 1.46% | -1.08% | 3.27% | 4.91% | -16.30% |
| Inhibrx, Inc. | INBX:USAINBX:USA | Stock | 1 | 1,618 | 0.41% | 0.26% | -1.44% | -11.04% | 113.17% | 26.90% |
| MoonLake Immunotherapeutics | MLTX:USAMLTX:USA | Stock | 1 | 2,737 | 6.32% | 6.52% | -1.59% | -23.11% | -4.37% | 84.28% |
| Ionis Pharmaceuticals, Inc. | IONS:USAIONS:USA | Stock | 1 | 6,058 | -2.60% | 0.91% | -2.01% | -15.09% | -4.02% | 16.65% |
| Johnson & Johnson | JNJ:USAJNJ:USA | Stock | 1 | 359,252 | -0.43% | 2.14% | -2.12% | -3.46% | 0.91% | -5.10% |
| Prime Medicine, Inc. | PRME:USAPRME:USA | Stock | 1 | 544 | -0.36% | 26.33% | -3.45% | -13.60% | -15.69% | -63.03% |
| Pliant Therapeutics, Inc. | PLRX:USAPLRX:USA | Stock | 1 | 838 | 5.51% | 18.37% | -3.92% | -11.52% | -7.05% | -38.36% |
| Intellia Therapeutics, Inc. | NTLA:USANTLA:USA | Stock | 1 | 2,195 | 1.42% | 13.68% | -5.49% | -4.99% | -10.88% | -45.93% |
| Nurix Therapeutics, Inc. | NRIX:USANRIX:USA | Stock | 1 | 628 | 0.39% | 3.40% | -8.32% | 51.96% | 130.06% | 35.38% |
| CRISPR Therapeutics AG | CRSP:USACRSP:USA | Stock | 1 | 4,474 | 1.49% | 3.67% | -14.09% | -13.36% | 21.03% | 5.21% |
| Altimmune, Inc. | ALT:USAALT:USA | Stock | 1 | 516 | 1.53% | 0.55% | -17.98% | -22.26% | 185.16% | 47.77% |
| Beam Therapeutics, Inc. | BEAM:USABEAM:USA | Stock | 1 | 1,888 | 1.80% | 8.19% | -20.32% | -10.80% | 7.88% | -30.48% |
| Bausch Health Cos., Inc. | BHC:USABHC:USA | Stock | 1 | 2,867 | -3.34% | -10.22% | -22.19% | 0.64% | 6.54% | 32.77% |
| Ocular Therapeutix, Inc. | OCUL:USAOCUL:USA | Stock | 1 | 709 | 5.11% | 30.03% | -27.15% | 24.65% | 88.69% | 1.31% |
* Colors indicate performance relative to the benchmark.